Our observation of higher SEMA3C expression in breast cancer cell lines corroborates the clinical observation made earlier, in which the transcript levels of SEMA3C were higher in breast cancer tissues as compared to adjacent normal mammary tissues [13]. This evidence concerns the gene SEMA3C and breast carcinoma.